MKTP with Surgical Blade for Vitiligo

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
VitiligoSuction blister grafting without cell dissociation - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the efficacy of three different methods for harvesting skin cells for transplantation in the treatment of vitiligo.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: 6 months

6 months
Percentage of change in the transplanted areas
Percentage of change in the transplanted areas in the transplanted areas
Rate of Complication
Time of healing

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

MKTP with Surgical Blade
1 of 3
MKTP with Negative Pressure Instrument
1 of 3
Suction blister grafting without cell dissociation
1 of 3

Experimental Treatment

17 Total Participants · 3 Treatment Groups

Primary Treatment: MKTP with Surgical Blade · No Placebo Group · N/A

MKTP with Surgical Blade
Procedure
Experimental Group · 1 Intervention: MKTP with Surgical blade · Intervention Types: Procedure
MKTP with Negative Pressure Instrument
Device
Experimental Group · 1 Intervention: MKTP with Negative Pressure Instrument · Intervention Types: Device
Suction blister grafting without cell dissociation
Device
Experimental Group · 1 Intervention: Suction blister grafting without cell dissociation · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

University of California, IrvineLead Sponsor
500 Previous Clinical Trials
1,881,435 Total Patients Enrolled
Anand K Ganesan, MD, PhDPrincipal InvestigatorUniversity of California, Irvine

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: